Breaking News Instant updates and real-time market news.

CIEN

Ciena

$23.74

-0.04 (-0.17%)

, LITE

Lumentum

$49.20

-0.25 (-0.51%)

04:55
03/21/17
03/21
04:55
03/21/17
04:55

UBS to hold meetings at OFC 2017

Company Meetings at OFC 2017 will be held in Los Angeles on March 20-21.

CIEN

Ciena

$23.74

-0.04 (-0.17%)

LITE

Lumentum

$49.20

-0.25 (-0.51%)

OCLR

Oclaro

$9.59

0.025 (0.26%)

ACIA

Acacia Communications

$54.09

-0.93 (-1.69%)

FNSR

Finisar

$27.25

-0.11 (-0.40%)

INFN

Infinera

$10.91

-0.22 (-1.98%)

  • 21

    Mar

  • 21

    Mar

  • 21

    Mar

  • 21

    Mar

  • 21

    Mar

  • 23

    Mar

  • 04

    Apr

  • 05

    Apr

  • 09

    May

  • 30

    May

CIEN Ciena
$23.74

-0.04 (-0.17%)

03/16/17
GSCO
03/16/17
DOWNGRADE
Target $27
GSCO
Neutral
Ciena downgraded to Neutral from Conviction Buy at Goldman
Goldman Sachs analyst Doug Clark downgraded Ciena to Neutral citing rising competition and his expectations for limited margin upside going forward. The analyst keeps a $27 price target for the shares.
03/09/17
COWN
03/09/17
NO CHANGE
Target $35
COWN
Outperform
Ciena weakness a buying opportunity, says Cowen
Cowen analyst Paul Silverstein noted Ciena reported disappointing Q2 operating results but he also saw some positives in the report. Silverstein said the results offered support for a long-term positive view with improving visibility, increasing revenue diversification, and strong trends in its key product markets. Silverstein reiterated his Outperform rating and $35 price target on Ciena shares and views weakness after earnings as a buying opportunity.
03/09/17
NEED
03/09/17
NO CHANGE
Target $30
NEED
Buy
Needham remains a buyer of Ciena despite 'light results'
Needham analyst Alex Henderson says that while Ciena missed forecasts and offered a bit light guide, demand was robust, even a bit stronger than expected, and the pipeline accelerated despite the normal seasonal weakness of the January quarter. The miss was all in Service Revenues, which should snap back to trend line while Products and Software sales came in ahead of forecast, he points out. Henderson remains a buyer of the shares, reiterating a Buy rating and $30 price target on the stock.
03/09/17
BMOC
03/09/17
NO CHANGE
BMOC
Ciena should be bought on weakness, says BMO Capital
BMO Capital analyst Tim Long says that Ciena's weakness following its results was overdone. The analyst says that the company's demand metrics were "strong," while "2017 is shaping up largely as expected." Long continues to "view Ciena as a clear winner in the optical space," and he keeps a $30 price target and an Outperform rating on the stock.
LITE Lumentum
$49.20

-0.25 (-0.51%)

03/16/17
BNCH
03/16/17
NO CHANGE
Target $40
BNCH
Buy
II-VI selloff a buying opportunity, says Benchmark
Benchmark analyst Mark Miller noted that a recent selloff in several optical telecom equipment stocks - including II-VI (IIVI), Lumentum (LITE), and Oclaro (OCLR) - has followed the disappointing earnings and guidance issued by Finisar (FNSR). Additionally weighing on II-VI was technical selling after its stock fell below its 50-day moving average, Miller tells investors. He said he views the selloff in II-VI as a buying opportunity and keeps a Buy rating and $40 price target on the shares.
03/16/17
GSCO
03/16/17
UPGRADE
Target $45
GSCO
Neutral
Lumentum upgraded to Neutral from Sell at Goldman
Goldman Sachs analyst Doug Clark upgraded Lumentum to Neutral saying 3D sensing capabilities is likely to be seen in upcoming flagship smartphones. The analyst raised his 3D sensing estimates and upped his price target for the shares to $45 from $38.
02/27/17
02/27/17
DOWNGRADE
Target $50

Neutral
Lumentum downgraded to Neutral on valuation at MKM Partners
As previously reported, MKM Partners downgraded Lumentum to Neutral from Buy and maintained its $50 price target. Analyst Michael Genovese said demand conditions in China are not as strong as last year and there are technology transitions in Chinese Optical. He believes Lumentum will lose share in Chinese line-side and client-side transmission and believes shares reflect a lot of potential good 3D sensing news.
02/27/17
02/27/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Tesla (TSLA) downgraded to Sell from Neutral at Goldman by analyst David Tamberrino, who also lowered his price target for the shares to $185 from $190. The analyst has concerns over the execution of the Model 3 launch, the company's "unproven" solar business as well as its near-term cash needs. 2. Under Armour (UAA) downgraded to Reduce from Neutral at Nomura by analyst Simeon Siegel, who cut his price target to $16 from $27, saying the company's Q4 report affirmed many of his concerns. Siegel is concerned Under Armour has matured past its high growth phase, and even in an overly optimistic scenario, believes shares are fairly valued at best and anything short of perfection could pressure shares as slowing growth rates normalize the lofty multiple. 3. Urban Outfitters (URBN) downgraded to Sell at MKM Partners by analyst Roxanne Meyer, who expects sales and margins to deteriorate meaningfully in 2017 at Anthropologie, and sees risk at the flagship brand as it laps reductions in markdowns and as key brands widen distribution. 4. Lumentum (LITE) downgraded to Neutral from Buy at MKM Partners by analyst Michael Genovese, who said demand conditions in China are not as strong as last year and there are technology transitions in Chinese Optical. He believes Lumentum will lose share in Chinese line-side and client-side transmission and believes shares reflect a lot of potential good 3D sensing news. 5. J.C. Penney (JCP) downgraded to Neutral from Buy at B. Riley by analyst Jeff Van Sinderen, who cut his price target for the shares to $7.50 from $12 following the company's Q4 results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
OCLR Oclaro
$9.59

0.025 (0.26%)

03/15/17
CHLM
03/15/17
NO CHANGE
CHLM
Buy
Oclaro a 'great buying opportunity,' says Craig-Hallum
Craig-Hallum analyst Richard Shannon believes Oclaro (OCLR) is a "great buying opportunity" at current prices. The analyst says concerns about China inventory are unfounded as there does not appear to be any ZTE (ZTCOY)-related issues, while NeoPhotonics (NPTN) dynamics are distinctly different than Oclaro's. Shannon notes that the latter's stock is "easily the cheapest" in the optical universe, suggesting very low downside risk and making it his best idea in the space. He reiterates a Buy rating on Oclaro's shares.
03/08/17
CHLM
03/08/17
NO CHANGE
CHLM
Buy
ZTE settlement removes overhang on Oclaro shares, says Craig-Hallum
Craig-Hallum analyst Richard Shannon notes that Oclaro (OCLR) top customer ZTE (ZTCOY) has settled with the U.S. and has agreed to a $1.2B fine. The analyst believes this eliminates the overhang on Oclaro's stock that has been there for the past year. The remaining issue with most investors is potential China inventory, which he believes is overblown. Shannon reiterates a Buy rating on Oclaro's shares.
03/03/17
CHLM
03/03/17
NO CHANGE
CHLM
Buy
Oclaro should be bought on potential ZTE settlement, says Craig-Hallum
Craig-Hallum analyst Richard Shannon believes Oclaro should be bought as news emerges that ZTE may settle with the U.S. Department of Commerce and permanently remove restrictions. The analyst says Oclaro's stock has been affected by ZTE as well as fears about a slowdown in China, which are overblown for the company. He reiterates a Buy rating on the shares.
ACIA Acacia Communications
$54.09

-0.93 (-1.69%)

02/13/17
DBAB
02/13/17
NO CHANGE
Target $125
DBAB
Buy
Acacia oversold ahead of Q4 results, says Deutsche Bank
Deutsche Bank analyst Vijay Bhagavath says he's a buyer of Acacia Communications into the company's Q4 results on February 23. The analyst expects a "modest beat and raise" quarter against what he calls a "conservative consensus view." Bhagavath views the stock as oversold at current levels and reiterates a Buy rating on the name with a $125 price target.
02/02/17
02/02/17
UPGRADE
Target $80

Overweight
Acacia Communications upgraded on valuation at Morgan Stanley
As previously reported, Morgan Stanley upgraded Acacia Communications to Overweight from Equal Weight with an $80 price target. Analyst Meta Marshall said Acacia shares have fallen approximately 50% over the past few months on customer concentration concerns. Marshall is confident in the company's ability to meet his estimates and believes the multiyear upgrade cycle opportunity and ability to maintain gross margins outweigh concerns.
02/15/17
RSBL
02/15/17
NO CHANGE
RSBL
Optical spending for March weak due to pushed out projects, says Rosenblatt
Rosenblatt said ZTe and Huawei's optical component inventory levels are high and believe believe their optical shipments are flattish year-over-year in Q1. Both ZTE and Huawei have tried to build inventory with concerns of the US government potentially sanctioning Chinese telecom vendors. Rosenblatt believes the strength that US component suppliers are seeing from Huawei and ZTE for the March quarter might be due to some double ordering and that ZTE and Huawei have about 2-3 and 1-1.5 months of inventory.
02/24/17
CHLM
02/24/17
NO CHANGE
CHLM
Acacia Communications weak guide may impact optical space, says Craig-Hallum
Craig-Hallum analyst Richard Shannon believes the weak guide from Acacia Communications may have an impact on the optical space. The analyst says weakness is mostly from a single customer that is burning inventory related to its DCI business, but whose Q1 guidance was also good. Shannon notes that the company indicated that DCI, Metro and China market appear healthy, which would suggest a temporary issue.
FNSR Finisar
$27.25

-0.11 (-0.40%)

03/15/17
JEFF
03/15/17
UPGRADE
Target $34
JEFF
Buy
Finisar upgraded to Buy from Hold at Jefferies
Jefferies analyst James Kisner upgraded Finisar to Buy saying the current valuation discounts no recovery in China and no resolution of recent technical issues. The analyst views the company's issues as temporary and upped his price target for the shares to $34 from $32.
03/15/17
03/15/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Netflix (NFLX) upgraded to Hold from Underperform at Jefferies with analyst John Janedis saying he believes Netflix's international growth opportunity is larger than he had expected. The company's original content is performing well, mobile consumption is growing and competition appears limited, Janedis tells investors in a research note. 2. CSX (CSX) upgraded to Overweight from Neutral at Atlantic Equities. 3. Amec Foster Wheeler (AMFW) was upgraded to Neutral from Underperform at Exane BNP Paribas and to Outperform from Market Perform at Raymond James. 4. Harley-Davidson (HOG) upgraded to Neutral from Underperform at Longbow. 5. Finisar (FNSR) upgraded to Buy from Hold at Jefferies with analyst James Kisner saying the current valuation discounts no recovery in China and no resolution of recent technical issues. The analyst views the company's issues as temporary and upped his price target for the shares to $34 from $32. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/13/17
03/13/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Needham analyst N. Quinn Bolton upgraded Marvell (MRVL) to Buy from Hold, with a $21 price target, following the company's inaugural analyst day, in which management laid out its strategy to grow revenue, further streamline operations and increase capital returns to shareholders. 2. Raymond James analyst Simon Leopold upgraded Finisar (FNSR) to Strong Buy from Outperform citing the 23% selloff in shares on Friday. The analyst believes the company's execution issues are "either misunderstood or exaggerated." He sees upside to estimates and has a $40 price target for the shares. 3. Morgan Stanley analyst Rajeev Lalwani upgraded Rockwell Collins (COL) to Overweight from Equal Weight and raised his price target for the shares to $121 from $94. 4. Citi analyst Michael Rollins upgraded Equinix (EQIX) to Buy from Neutral citing prospects for faster growth from the company's European portfolio as well as acquisitions. The analyst raised his price target for the shares to $435. 5. Goldman Sachs analyst Terence Flynn upgraded Blueprint Medicines (BPMC) to Buy from Neutral citing pipeline momentum following last year's data readouts. The analyst expects a "steady flow" of readouts at conferences this year from the extension phases of trials and clarity on potential registration paths. He upped his price target for the shares to $52 from $35. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
INFN Infinera
$10.91

-0.22 (-1.98%)

03/16/17
GSCO
03/16/17
UPGRADE
Target $13.5
GSCO
Buy
Infinera upgraded to Buy from Neutral at Goldman
Goldman Sachs analyst Doug Clark upgraded Infinera to Buy and raised his price target for the shares to $13.50 from $10. Revenue recognition from new products should start in Q2 and progress into 2018, Clark tells investors in a research note.
01/19/17
01/19/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Nike (NKE) and lululemon (LULU) were initiated with an Underperform at CLSA, while the firm initiated Under Armour (UA, UAA) with a Buy. 2. Comcast (CMCSA) was initiated with a Buy at HSBC, while Charter (CHTR) was initiated with a Hold. 3. Brookfield (BAM) initiated with a Buy at Citi. 4. Apogee Enterprises (APOG) initiated with a Buy at Craig-Hallum. 5. Infinera (INFN) initiated with a Neutral at Piper Jaffray. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/10/17
NOMU
02/10/17
UPGRADE
NOMU
Buy
Infinera upgraded to Buy from Neutral at Nomura
02/10/17
02/10/17
UPGRADE

Buy
Infinera upgraded to Buy, estimates set to improve in 2017, says Nomura
As previously reported, Nomura upgraded Infinera to Buy from Neutral and raised its price target to $15 from $8. Analyst Jeffrey Kvaal said Infinera reported disappointing March guidance but strengthening in Europe/webscale and solidifying product roadmap increase visibility to sequential growth through 2017. Kvaal expects margins to be stable in 1H before rising with higher sales and the new PIC chip.

TODAY'S FREE FLY STORIES

PINC

Premier

$34.21

0.04 (0.12%)

20:14
10/23/17
10/23
20:14
10/23/17
20:14
Downgrade
Premier rating change  »

Premier downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VBTX

Veritex

$26.94

-0.17 (-0.63%)

19:29
10/23/17
10/23
19:29
10/23/17
19:29
Earnings
Veritex reports Q3 core EPS 28c, consensus 30c »

For the three months…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

OIBR

Oi S.A.

19:08
10/23/17
10/23
19:08
10/23/17
19:08
Hot Stocks
Oi: Court postpones general meeting of creditors »

Oi announced that, at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAS

Hasbro

$89.75

-8.44 (-8.60%)

18:24
10/23/17
10/23
18:24
10/23/17
18:24
Hot Stocks
Hasbro CEO: Had a very strong quarter »

Expects to make a revised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

LGF.A

Lionsgate

$29.59

-0.5 (-1.66%)

, LGF.B

Lionsgate

$28.44

-0.6 (-2.07%)

18:07
10/23/17
10/23
18:07
10/23/17
18:07
Hot Stocks
Lionsgate names Rohit Jain to head new office in Mumbai, India »

Lionsgate (LGF.A, LGF.B)…

LGF.A

Lionsgate

$29.59

-0.5 (-1.66%)

LGF.B

Lionsgate

$28.44

-0.6 (-2.07%)

DISH

Dish

$48.98

-0.32 (-0.65%)

VDTH

Videocon d2h

$8.00

-0.22 (-2.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

  • 09

    Nov

ALE

Allete

$78.62

-0.31 (-0.39%)

18:06
10/23/17
10/23
18:06
10/23/17
18:06
Hot Stocks
Wisconsin jury delivers verdict in favor of U.S. Water in Novozymes suit »

U.S. Water, an Allete…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 05

    Nov

SYT

Syngenta

$92.12

0.05 (0.05%)

, ADAM

A.D.A.M.

18:04
10/23/17
10/23
18:04
10/23/17
18:04
Hot Stocks
Syngenta and Adama to sell portfolio of crop products to Nufarm for $490M »

Syngenta (SYT) announced…

SYT

Syngenta

$92.12

0.05 (0.05%)

ADAM

A.D.A.M.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$98.70

-0.7 (-0.70%)

17:54
10/23/17
10/23
17:54
10/23/17
17:54
Periodicals
Disney sees new 'Thor' movie outpacing earlier ones, Bloomberg says »

Disney sees "Thor:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

VIVO

Meridian Bioscience

$15.20

-0.6 (-3.80%)

17:31
10/23/17
10/23
17:31
10/23/17
17:31
Hot Stocks
Meridian Bioscience comments on FDA Warning Letter issued to subsidiary »

Meridian Bioscience…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APRN

Blue Apron

$5.15

0.07 (1.38%)

17:30
10/23/17
10/23
17:30
10/23/17
17:30
Hot Stocks
Blue Apron names Lainie Cooney chief HR officer »

Blue Apron announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

WSFS

WSFS Financial

$50.25

-0.5 (-0.99%)

17:29
10/23/17
10/23
17:29
10/23/17
17:29
Hot Stocks
WSFS Financial raises quarterly dividend 29% to 9c per share »

The dividend will be paid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 06

    Nov

  • 15

    Nov

CONN

Conn's

$26.85

-0.75 (-2.72%)

17:28
10/23/17
10/23
17:28
10/23/17
17:28
Hot Stocks
Conn's sees Q3 SSS down 9% to down 5%, provision for bad debts at $56M-$61M »

The company states:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WSFS

WSFS Financial

$50.25

-0.5 (-0.99%)

17:27
10/23/17
10/23
17:27
10/23/17
17:27
Earnings
WSFS Financial reports Q3 EPS 64c, consensus 65c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 06

    Nov

  • 15

    Nov

VBTX

Veritex

$26.94

-0.17 (-0.63%)

17:27
10/23/17
10/23
17:27
10/23/17
17:27
Hot Stocks
Veritex names Michael Bryan chief information officer »

Veritex Holdings, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

TNDM

TNDM

17:25
10/23/17
10/23
17:25
10/23/17
17:25
Hot Stocks
Breaking Hot Stocks news story on TNDM »

Armistice Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

CLB

Core Laboratories

$87.75

-1.74 (-1.94%)

17:21
10/23/17
10/23
17:21
10/23/17
17:21
Hot Stocks
Core Laboratories sees Q4 free cash flow exceeding net income »

Fourth quarter 2017 FCF…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

CLB

Core Laboratories

$87.75

-1.74 (-1.94%)

17:20
10/23/17
10/23
17:20
10/23/17
17:20
Earnings
Core Laboratories sees Q4 revenue approximately 58c, consensus 58c »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

CLB

Core Laboratories

$87.75

-1.74 (-1.94%)

17:18
10/23/17
10/23
17:18
10/23/17
17:18
Earnings
Core Laboratories reports Q3 GAAP EPS 48c, consensus 44c »

Reports Q3 revenue $166M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

LKQ

LKQ Corp.

$37.06

-0.28 (-0.75%)

, DOV

Dover

$95.54

0.59 (0.62%)

17:17
10/23/17
10/23
17:17
10/23/17
17:17
Hot Stocks
LKQ Corp to acquire aftermarket business of Dover subsidiary Warn Industries »

LKQ Corporation (LKQ)…

LKQ

LKQ Corp.

$37.06

-0.28 (-0.75%)

DOV

Dover

$95.54

0.59 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

KNL

Knoll

$20.00

-0.02 (-0.10%)

, HMST

HomeStreet

$28.60

-0.25 (-0.87%)

17:17
10/23/17
10/23
17:17
10/23/17
17:17
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Knoll…

KNL

Knoll

$20.00

-0.02 (-0.10%)

HMST

HomeStreet

$28.60

-0.25 (-0.87%)

CR

Crane

$83.61

-0.5 (-0.59%)

IPXL

Impax

$20.35

-0.9 (-4.24%)

ICPT

Intercept

$65.60

-1.25 (-1.87%)

SWK

Stanley Black & Decker

$158.19

-1.93 (-1.21%)

NKE

Nike

$53.66

0.6 (1.13%)

HNI

HNI Corporation

$42.29

-0.57 (-1.33%)

WHR

Whirlpool

$182.50

0.04 (0.02%)

ZION

Zions Bancorp

$46.39

-0.37 (-0.79%)

JBT

John Bean Technologies

$104.05

0.1 (0.10%)

IMDZ

Immune Design

CRBP

Corbus Pharmaceuticals

$7.40

-0.375 (-4.82%)

QURE

uniQure

$18.52

-0.75 (-3.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 06

    Nov

  • 08

    Nov

  • 09

    Nov

  • 09

    Nov

  • 13

    Nov

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

HBI

Hanesbrands

$22.86

-0.63 (-2.68%)

17:17
10/23/17
10/23
17:17
10/23/17
17:17
Initiation
Hanesbrands initiated at Deutsche Bank »

Hanesbrands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

PVH

PVH Corp.

$129.68

1.37 (1.07%)

17:15
10/23/17
10/23
17:15
10/23/17
17:15
Initiation
PVH Corp. initiated at Deutsche Bank »

PVH Corp. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NYT

New York Times

$19.55

0.1 (0.51%)

17:15
10/23/17
10/23
17:15
10/23/17
17:15
Hot Stocks
Breaking Hot Stocks news story on New York Times »

Darsana Capital Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$1.01

0.01 (1.00%)

17:07
10/23/17
10/23
17:07
10/23/17
17:07
Hot Stocks
U.S. Energy announces participation in upcoming drilling program »

U.S. Energy announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KOS

Kosmos

$7.44

-0.07 (-0.93%)

, HES

Hess Corp.

$45.21

0.18 (0.40%)

17:05
10/23/17
10/23
17:05
10/23/17
17:05
Hot Stocks
Kosmos to acquire interest in exploration licenses in Gulf of Guinea for $650M »

Kosmos Energy announced…

KOS

Kosmos

$7.44

-0.07 (-0.93%)

HES

Hess Corp.

$45.21

0.18 (0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 06

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.